SkinBioTherapeutics has appointed Alyson Levett as a non-executive director and chair of its audit committee.

The AIM-listed life science company focused on skin health has also promoted Emily Bertram from group finance director to CFO, and also to its board.

Current NED Danielle Bekker has stepped down from the board but will continue to support as an external advisor.

Levett has over 20 years C-suite financial experience, culminating in being CFO at the strategy software company, i-nexus where she stayed for a decade taking it onto AIM in a successful IPO in 2018.